Spatiotemporal regulation of angiogenesis/osteogenesis emulating natural bone healing cascade for vascularized bone formation

J Nanobiotechnology. 2021 Dec 14;19(1):420. doi: 10.1186/s12951-021-01173-z.

Abstract

Engineering approaches for growth factor delivery have been considerably advanced for tissue regeneration, yet most of them fail to provide a complex combination of signals emulating a natural healing cascade, which substantially limits their clinical successes. Herein, we aimed to emulate the natural bone healing cascades by coupling the processes of angiogenesis and osteogenesis with a hybrid dual growth factor delivery system to achieve vascularized bone formation. Basic fibroblast growth factor (bFGF) was loaded into methacrylate gelatin (GelMA) to mimic angiogenic signalling during the inflammation and soft callus phases of the bone healing process, while bone morphogenetic protein-2 (BMP-2) was bound onto mineral coated microparticles (MCM) to mimics osteogenic signalling in the hard callus and bone remodelling phases. An Initial high concentration of bFGF accompanied by a sustainable release of BMP-2 and inorganic ions was realized to orchestrate well-coupled osteogenic and angiogenic effects for bone regeneration. In vitro experiments indicated that the hybrid hydrogel markedly enhanced the formation of vasculature in human umbilical vein endothelial cells (HUVECs), as well as the osteogenic differentiation of mesenchymal stem cells (BMSCs). In vivo results confirmed the optimal osteogenic performance of our F/G-B/M hydrogel, which was primarily attributed to the FGF-induced vascularization. This research presents a facile and potent alternative for treating bone defects by emulating natural cascades of bone healing.

Keywords: Angiogenesis; Growth factor; Hydrogel; Mineral coating; Osteogenesis.

MeSH terms

  • Bone Regeneration / drug effects
  • Bone and Bones / blood supply
  • Bone and Bones / drug effects
  • Cells, Cultured
  • Fibroblast Growth Factor 2* / chemistry
  • Fibroblast Growth Factor 2* / pharmacology
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Humans
  • Hydrogels* / chemistry
  • Hydrogels* / pharmacology
  • Methacrylates / chemistry
  • Neovascularization, Physiologic / drug effects*
  • Osteogenesis / drug effects*

Substances

  • Hydrogels
  • Methacrylates
  • Fibroblast Growth Factor 2